Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, December 13, 2021
[ Mon, Dec 13th 2021
] - WOPRAI
[ Mon, Dec 13th 2021
] - WOPRAI
[ Mon, Dec 13th 2021
] - WOPRAI
[ Mon, Dec 13th 2021
] - WOPRAI
[ Mon, Dec 13th 2021
] - WOPRAI
[ Mon, Dec 13th 2021
] - WOPRAI
Sun, December 12, 2021
[ Sun, Dec 12th 2021
] - WOPRAI
Fri, December 10, 2021
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
[ Fri, Dec 10th 2021
] - WOPRAI
Justin Kim Upgraded (AUPH) to Buy and Decreased Target to $31 on, Dec 10th, 2021
Justin Kim of Oppenheimer, Upgraded "Aurinia Pharmaceuticals Inc." (AUPH) to Buy and Decreased Target from $33 to $31 on, Dec 10th, 2021.
Justin has made no other calls on AUPH in the last 4 months.
There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 0 agree with Justin's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Justin
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $40 on, Thursday, November 4th, 2021
- Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $35 on, Thursday, November 4th, 2021
- Douglas Miehm of "RBC Capital" Maintained at Buy with Increased Target to $34 on, Tuesday, October 26th, 2021
